<DOC>
	<DOC>NCT00199745</DOC>
	<brief_summary>The primary objective of the study is to investigate whether differences in atorvastatin metabolite ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity. A muscle biopsy is also collected and investigated.</brief_summary>
	<brief_title>Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity</brief_title>
	<detailed_description>The primary objective of the study is to investigate whether differences in atorvastatin metabolites ratios might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity. A muscle biopsy is also collected and investigated.</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Suspected atorvastatin induced muscle adverse events Signed informed consent 18 years of age or older Able to donate blood samples Ongoing treatment with atorvastatin (not necessary if patients only donate a muscle biopsy)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>statin</keyword>
	<keyword>statins</keyword>
	<keyword>statin therapy</keyword>
	<keyword>adverse events</keyword>
	<keyword>side effect</keyword>
	<keyword>Myotoxicity</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>Atorvastatin Therapy</keyword>
</DOC>